𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parkinson's disease, melanoma, and levodopa

✍ Scribed by Joseph Fermaglich; Peyton Delaney

Book ID
104717176
Publisher
Springer
Year
1977
Tongue
English
Weight
239 KB
Volume
215
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Parkinson's disease, levodopa-use and th
Parkinson's disease, levodopa-use and the risk of melanoma
✍ J.-D. Vermeij; A. Winogrodzka; J. Trip; W.E.J. Weber πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 98 KB

Since the early 1970s, the literature has suggested an association between Parkinson's Disease (PD) and/ or levodopa-use and an increased risk for the development of malignant melanoma. In some countries, this possible association has even led to a warning in the drug insert leaflet of the possible

Parkinson's disease/Parkinson syndromesβ€”
Parkinson's disease/Parkinson syndromesβ€”therapy: Levodopa
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

Melanoma and Parkinson's disease
Melanoma and Parkinson's disease
✍ Edgar Selvaag; Tove Eeg Larsen; Per Thune πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 426 KB
Melanoma and Parkinson's disease
Melanoma and Parkinson's disease
✍ Edgar Selvaag; Tove Eeg Larsen; Per Thune πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 91 KB